Iron-Refractory Iron Deficiency Anemia

Seminars in Hematology

Volumn 46, Issue 4, 2009, Pages 378-386

  Finberg, Karin E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS SULFATE; HEMOJUVELIN; HEPCIDIN; IRON; IRON DEXTRAN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PROTEIN TMPRSS6; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG RESPONSE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON TRANSPORT; LIVER CELL; MALABSORPTION; MICROCYTIC ANEMIA; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; ANEMIA, REFRACTORY; ANTIMICROBIAL CATIONIC PEPTIDES; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATINICS; HUMANS; INFANT; INFUSIONS, PARENTERAL; IRON; IRON COMPOUNDS; LIVER; MALE; MEMBRANE PROTEINS; MUTATION; SERINE ENDOPEPTIDASES; TREATMENT FAILURE; UP-REGULATION;

EID: 70349309740     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2009.06.006     Document Type: Article

References (52)

1. Buchanan G.R., and Sheehan R.G. Malabsorption and defective utilization of iron in three siblings. J Pediatr 98 (1981) 723-728
2. Brown A.C., Lutton J.D., Pearson H.A., Nelson J.C., Levere R.D., and Abraham N.G. Heme metabolism and in vitro erythropoiesis in anemia associated with hypochromic microcytosis. Am J Hematol 27 (1988) 1-6
3. Hartman K.R., and Barker J.A. Microcytic anemia with iron malabsorption: an inherited disorder of iron metabolism. Am J Hematol 51 (1996) 269-275
4. Pearson H.A., and Lukens J.N. Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption. J Pediatr Hematol Oncol 21 (1999) 412-417
5. Andrews N.C. Iron deficiency: lessons from anemic mice. Yale J Biol Med 70 (1997) 219-226
6. Galanello R., Cau M., Melis M.A., Deidda F., Cao A., and Cazzola M. Studies of NRAMP2, transferrin receptor and transferrin genes as candidate genes for human hereditary microcytic anemia due to defective iron absorption and utilization [abstract]. ASH Annual Meeting Abstracts 92S (1998) 669a
7. Mayo M.M., and Samuel S.M. Iron deficiency anemia due to a defect in iron metabolism: a case report. Clin Lab Sci 14 (2001) 135-138
8. Finberg K.E., Heeney M.M., Campagna D.R., Aydinok Y., Pearson H.A., Hartman K.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40 (2008) 569-571
9. Melis M.A., Cau M., Congiu R., Sole G., Barella S., Cao A., et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 93 (2008) 1473-1479
10. Hartman K.R., Finberg K.E., and Merino M.E. Iron resistant iron deficiency anemia: long term follow-up of 5 patients [abstract]. ASPHO Annual Meeting Abstracts (2009)
11. Melis M.A., Cau M., Congiu R., Sole G., Cao A., and Galanello R. Identification of a gene involve in hereditary microcytic anemia due to defective iron absorption in a Sardinian family [abstract]. ESHG Annual Meeting Abstracts 15 S1 (2007) 261
12. Velasco G., Cal S., Quesada V., Sanchez L.M., and Lopez-Otin C. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem 277 (2002) 37637-37646
13. Du X., She E., Gelbart T., Truksa J., Lee P., Xia Y., et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 320 (2008) 1088-1092
14. Beutler E., Lee P., Gelbart T., Du X., and Beutler B. The mask mutation identifies Tmprss6 as an essential suppressor of hepcidin [abstract]. ASH Annual Meeting Abstracts 110 (2007) 9a
15. Netzel-Arnett S., Hooper J.D., Szabo R., Madison E.L., Quigley J.P., Bugge T.H., et al. Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 22 (2003) 237-258
16. Guillem F., Lawson S., Kannengiesser C., Westerman M., Beaumont C., and Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112 (2008) 2089-2091
17. Finberg K.E., Heeney M.M., Campagna D., Fleming M.D., and Andrews N.C. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia [abstract]. ASHG Annual Meeting Abstracts (2008) 317
18. The International HapMap Consortium. The International HapMap Project. Nature 426 (2003) 789-796
19. Lin C.Y., Anders J., Johnson M., Sang Q.A., and Dickson R.B. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 274 (1999) 18231-18236
20. Parr C., Sanders A.J., Davies G., Martin T., Lane J., Mason M.D., et al. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clin Cancer Res 13 (2007) 3568-3576
21. Sanders A.J., Parr C., Martin T.A., Lane J., Mason M.D., and Jiang W.G. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. J Cell Physiol 216 (2008) 780-789
22. Nemeth E., and Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26 (2006) 323-342
23. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
24. Kemna E.H., Tjalsma H., Podust V.N., and Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53 (2007) 620-628
25. Ganz T., Olbina G., Girelli D., Nemeth E., and Westerman M. Immunoassay for human serum hepcidin. Blood 112 (2008) 4292-4297
26. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
27. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107 (2006) 328-333
28. De Domenico I., Ward D.M., Langelier C., Vaughn M.B., Nemeth E., Sundquist W.I., et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18 (2007) 2569-2578
29. De Domenico I., Nemeth E., Nelson J.M., Phillips J.D., Ajioka R.S., Kay M.S., et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 8 (2008) 146-156
30. Folgueras A.R., Martin de Lara F., Pendas A.M., Garabaya C., Rodriguez F., Astudillo A., et al. The membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112 (2008) 2539-2545
31. Silvestri L., Pagani A., Nai A., De Domenico I., Kaplan J., and Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8 (2008) 502-511
32. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36 (2004) 77-82
33. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38 (2006) 531-539
34. Miyazono K., Maeda S., and Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16 (2005) 251-263
35. Iolascon A., De Falco L., and Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 94 (2009) 395-408
36. Mims M.P., Guan Y., Pospisilova D., Priwitzerova M., Indrak K., Ponka P., et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105 (2005) 1337-1342
37. Iolascon A., d'Apolito M., Servedio V., Cimmino F., Piga A., and Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107 (2006) 349-354
38. Beaumont C., Delaunay J., Hetet G., Grandchamp B., de Montalembert M., and Tchernia G. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 107 (2006) 4168-4170
39. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
40. Canonne-Hergaux F., Zhang A.S., Ponka P., and Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 98 (2001) 3823-3830
41. Bannerman R.M., Edwards J.A., Kreimer-Birnbaum M., McFarland E., and Russell E.S. Hereditary microcytic anaemia in the mouse; studies in iron distribution and metabolism. Br J Haematol 23 (1972) 235-245
42. Edwards J.A., and Hoke J.E. Red cell iron uptake in hereditary microcytic anemia. Blood 46 (1975) 381-388
43. Fleming M.D., Trenor III C.C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F., et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16 (1997) 383-386
44. Craven C.M., Alexander J., Eldridge M., Kushner J.P., Bernstein S., and Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci U S A 84 (1987) 3457-3461
45. Trenor III C.C., Campagna D.R., Sellers V.M., Andrews N.C., and Fleming M.D. The molecular defect in hypotransferrinemic mice. Blood 96 (2000) 1113-1118
46. Goldwurm S., Casati C., Venturi N., Strada S., Santambrogio P., Indraccolo S., et al. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 1 (2000) 390-398
47. Aslan D., Crain K., and Beutler E. A new case of human atransferrinemia with a previously undescribed mutation in the transferrin gene. Acta Haematol 118 (2007) 244-247
48. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
49. Chung A., Leo K., Wong G., Chuah K., Ren J., and Lee C. Giant hepatocellular adenoma presenting with chronic iron deficiency anemia. Am J Gastroenterol 101 (2006) 2160-2162
50. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
51. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
52. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023